Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2025-05-05 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (542 characters) and explicitly states 'Please read the announcement in PDF' and provides an attachment link. This structure indicates that the document itself is merely an announcement about the availability of a report, not the report content. The content concerns 'Transactions under Novonesis s share buyback program'. According to the definitions, reports on the company buying back or selling its own shares fall under 'Transaction in Own Shares' (POS). However, because this is an announcement pointing to the actual document, it fits the 'Report Publication Announcement' (RPA) definition best, as it announces the publication/availability of the detailed transaction report.
2025-05-05 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (542 characters) and explicitly states, 'Please read the announcement in PDF' and provides a link to an attachment titled '2025_20_Share_buyback_program'. This structure indicates that the document itself is merely an announcement pointing to the actual filing, not the detailed report. The content concerns a 'share buyback program,' which falls under the category of the company transacting in its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS). However, given the 'MENU VS MEAL' rule, since this is just an announcement pointing to the main document, it could also be considered a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since POS is a specific category for share transactions, and the announcement is about the *results* or *activity* of that program, POS is the primary fit for the subject matter, but RPA/RNS fits the *format* (announcement only). Given the specific subject matter (share buyback), POS is chosen, acknowledging the format suggests RPA/RNS might also apply if POS didn't exist. Since POS specifically covers 'Report of the company buying back or selling its own shares', this is the best fit for the subject matter.
2025-04-28 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 100% confidence The document explicitly details transactions under a 'share buyback program' for Novonesis, reporting the number of shares purchased, average price, and total transaction value for specific dates (April 21 to April 25, 2025). This content directly relates to the company acquiring its own shares. According to the definitions, the category 'Transaction in Own Shares (Code: POS)' covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document is a detailed report, not just an announcement of a report, and its length suggests it is the primary disclosure, making POS the most accurate classification.
2025-04-28 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (542 characters) and explicitly states 'Please read the announcement in PDF' and provides an attachment link. This indicates the document is an announcement about the availability of a report or transaction details, rather than the full report itself. The content specifically discusses 'Transactions under Novonesis s share buyback program'. According to the definitions, a report of the company buying back or selling its own shares is classified as 'Transaction in Own Shares' (POS). However, because this document is merely an announcement pointing to the actual details (the PDF), it fits the 'Report Publication Announcement' (RPA) criteria better, as it announces the publication/availability of the transaction details. Given the strong focus on share repurchase, POS is the underlying subject, but RPA is the document type based on the 'MENU VS MEAL' rule.
2025-04-22 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 100% confidence The document is titled "Transactions under Novonesis' share buyback program" and provides detailed daily transaction data (number of shares, average price, transaction value) for a specific period (April 14-18, 2025) related to a previously announced share buyback program. This activity directly corresponds to the company buying back or selling its own shares, which matches the definition for 'Transaction in Own Shares' (POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K) as it focuses solely on share transactions, not comprehensive financial performance. It is a specific regulatory disclosure regarding treasury stock movements.
2025-04-22 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 100% confidence The document explicitly discusses 'Transactions under Novonesis' share buyback program' and details the number of shares purchased, transaction values, and specific dates (April 7-11, 2025). This content directly relates to the company repurchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a Director's Dealing (DIRS) as it refers to a corporate program, not individual director trades.
2025-04-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.